Biotech stocks are gaining prominence due to companies searching for treatment for COVID. Due to the growing needs of the aging baby boomers, biotech is set to grow. There is no better investment in biotech than in an undervalued stock like Corcept Therapeutics (NASDAQ:)Corcept TherapeuticsCORT(*() It is involved with the development and commercialization drugs for severe metabolic, psychotic, or oncologic diseases by controlling cortisol levels. Your body’s stress hormone, cortisol. This hormone works together with your brain in order to manage your fear, mood and motivation.People will experience negative effects if they don’t get enough or too much cortisol. A lack of cortisol could lead to shock or a weakening immune system. CORT believes regulation of cortisol is crucial for treating many types of diseases.

Korlym is the only approved marketed drug for treating hyperglycemia secondary hypercortisolism among adult Cushing’s patients. Korlym, which was first approved by FDA for Cushing’s syndrome patients, is actually a novel drug. Korlym modulates cortisol, which is a difference from other medications. Patients could be harmed if cortisol production is stopped.

Disclaimer

Continue reading on StockNews